Skip to navigation Skip to content Skip to footer Help using this website - Accessibility statement

ResMed Inc.

Developer, manufacturer, supplier, distributor and marketing of medical devices and cloud-based software applications for treating, diagnosing, and managing sleep-disordered breathing and other respiratory disorders.

RMD$32.840

-0.260 -0.79%

Data last updated:May 17, 2024 – 3.58pm. Data is 20 mins delayed.

Overview

1 day1 d 5 days5 d 1 month1 m 3 months3 m 1 year1 y 5 years5 y

Previous Close	33.100
Open	32.740
Day Range	32.740 - 33.070
52 Week Range	21.140 - 34.390
Volume	819,885
Value	26,987,694

Bid	32.820
Ask	32.840
Dividend Yield	0.88%
P/E Ratio	33.73
Market Cap	48.230B
Total Issue	1,468,866,830

ASX Announcements

Update - Dividend/Distribution - RMD

Dividend Record Date, Dividend Pay Date, Dividend Rate

May 10, 2024
4 pages

Statement of CDIs on issue - RMD

Alternation to issued capital

May 3, 2024
3 pages

Market Sensitive

Form 10-Q for the Quarter ended March 31, 2024

Periodic Reports - Other

Apr 29, 2024
43 pages

Market Sensitive

Dividend/Distribution - RMD

Dividend Record Date, Dividend Pay Date, Dividend Rate

Apr 26, 2024
4 pages

Market Sensitive

ResMed Announces Results for the Third Quarter of FY2024

Periodic Reports - Other

Apr 26, 2024
10 pages

View all RMD announcements

TODAY

No stories for ResMed Inc. are available.

Search afr.com for ResMed Inc. stories

Copyright © 2024. Company information displayed on The Australian Financial Review is sourced from Morningstar and ASX and is subject to their terms and conditions as set out in our Terms of Use. The Australian Financial Review does not accept any responsibility for the accuracy and/or completeness of such data or information.